Publikationen von Frank Weber

Kuempfel, T.; Schwan, M.; Weber, F.; Holsboer, F.; Trenkwalder, C.; Bergh, F. T.: Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis. PSYCHONEUROENDOCRINOLOGY 45, S. 87 - 95 (2014)

Nischwitz, S.; Faber, H.; Saemann, P. G.; Domingues, H. S.; Krishnamoorthy, G.; Knop, M.; Müller-Sarnowski, F.; Yassouridis, A.; Weber, F.: Interferon-1a reduces increased interleukin-16 levels in multiple sclerosis patients. ACTA NEUROLOGICA SCANDINAVICA 130 (1), S. 46 - 52 (2014)

Galea, I.; Lederer, B.; Neuhaus, A.; Muraro, P. A.; Scalfari, C.; Koch-Henriksen, N.; Heesen, C.; Koepke, S.; Stellmann, P.; Albrecht, H. et al.; Winkelmann, A.; Weber, F.; Bahn, E.; Hauser, M.; Edan, G.; Ebers, G.; Daumer, M.: A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis. EUROPEAN JOURNAL OF NEUROLOGY 20 (7), S. 1107 - 1109 (2013)

Faber, H.; Fischer, H.-J.; Weber, F.: Prolonged and symptomatic bradycardia following a single dose of fingolimod. MULTIPLE SCLEROSIS JOURNAL 19 (1), S. 126 - 128 (2013)

Hahn, F.; Faber, H.; Weber, P.; Pütz, B.; Knop, M.; Nischwitz, S.; Weber, F.: Methylprednisolone-regulated genes affecting multiple sclerosis pathogenesis. Journal of Neurology 259 (Suppl. 1), S. S13 - S13 (2012)

Nischwitz, S.; Müller-Myhsok, B.; Weber, F.: Risk conferring genes in multiple sclerosis. FEBS Letters 585 (23), S. 3789 - 3797 (2011)

Havla, J.; Gerdes, L. A.; Meinl, I.; Krumbholz, M.; Faber, H.; Weber, F.; Pellkofer, H. L.; Hohlfeld, R.; Kümpfel, T.: De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate. Journal of Neurology 258 (9), S. 1665 - 1669 (2011)

Maccarrone, G.; Nischwitz, S.; Deininger, S. O.; Hornung, J.; König, F. B.; Stadelmann, C.; Turck, C. W.; Weber, F.: MALDI imaging - a new tool for mapping multiple sclerosis brain lesions. Pharmacopsychiatry 44 (6), S. 300 - 300 (2011)

Pröbstel, A. K.; Dornmair, K.; Bittner, R.; Sperl, P.; Jenne, D.; Magalhaes, S.; Villalobos, A.; Breithaupt, C.; Weissert, R.; Jacob, U. et al.; Krumbholz, M.; Kuempfel, T.; Blaschek, A.; Stark, W.; Gartner, J.; Pohl, D.; Rostasy, K.; Weber, F.; Forne, I.; Khademi, M.; Olsson, T.; Brilot, F.; Tantsis, E.; Dale, R. C.; Wekerle, H.; Hohlfeld, R.; Banwell, B.; Bar-Or, A.; Meinl, E.; Derfuss, T.: Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 77 (6), S. 580 - 588 (2011)

Nischwitz, S.; Cepok, S.; Kroner, A.; Wolf, C.; Knop, M.; Müller-Sarnowski, F.; Pfister, H.; Rieckmann, P.; Hemmer, B.; Ising, M. et al.; Uhr, M.; Bettecken, T.; Holsboer, F.; Müller-Myhsok, B.; Weber, F.: More CLEC16A gene variants associated with multiple sclerosis. Acta Neurologica Scandinavica 123 (6), S. 400 - 406 (2011)

Sämann, P. G.; Kloiber, S.; Uhr, M.; Schumann-Späth, E.; Weber, F.: Nervous system affection in Evans' syndrome: case report and first description. Journal of Neurology 258 (Suppl. 1), S. 214 - 215 (2011)

Kam-Thong, T.; Czamara, D.; Tsuda, K.; Borgwardt, K.; Lewis, C. M.; Erhardt-Lehmann, A.; Hemmer, B.; Rieckmann, P.; Daake, M.; Weber, F. et al.; Wolf, C.; Ziegler, A.; Pütz, B.; Holsboer, F.; Schölkopf, B.; Müller-Myhsok, B.: EPIBLASTER-fast exhaustive two-locus epistasis detection strategy using graphical processing units. European Journal of Human Genetics 19 (4), S. 465 - 471 (2011)

Couturier, N.; Bucciarelli, F.; Nurtdinov, R. N.; Debouverie, M.; Lebrun-Frenay, C.; Defer, G.; Moreau, T.; Confavreux, C.; Vukusic, S.; Cournu-Rebeix, I. et al.; Goertsches, R. H.; Zettl, U. K.; Comabella, M.; Montalban, X.; Rieckmann, P.; Weber, F.; Müller-Myhsok, B.; Edan, G.; Fontaine, B.; Mars, L. T.; Saoudi, A.; Oksenberg, J. R.; Clanet, M.; Liblau, R. S.; Brassat, D.: Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Brain 134, S. 693 - 703 (2011)

Nischwitz, S.; Cepok, S.; Kroner, A.; Wolf, C.; Knop, M.; Müller-Sarnowski, F.; Pfister, H.; Roeske, D.; Rieckmann, P.; Hemmer, B. et al.; Ising, M.; Uhr, M.; Bettecken, T.; Holsboer, F.; Müller-Myhsok, B.; Weber, F.: Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. Journal of Neuroimmunology 227 (1-2), S. 162 - 166 (2010)

Sämann, P. G.; Knop, M.; Nischwitz, S.; Czisch, M.; Weber, F.: USPIO-gestützte Charakterisierung der weißen Substanz bei MS. Nervenarzt 81 (Suppl. 1), S. 18 - 19 (2010)

Dresler, M.; Genzel, L.; Kluge, M.; Schüssler, P.; Weber, F.; Rosenhagen, M.; Steiger, A.: Off-line memory consolidation impairments in multiple sclerosis patients receiving high-dose corticosteroid treatment mirror consolidation impairments in depression. Psychoneuroendocrinology 35 (8), S. 1194 - 1202 (2010)

Nischwitz, S.; Sämann, P. G.; Knop, M.; Müller-Sarnowski, F.; Faber, H.; Yassouridis, A.; Weber, F.: Modulation of interleukin-16 by interferon beta-1a treatment in patients with multiple sclerosis. Journal of Neurology 257 (Suppl. 1), S. S218 - S219 (2010)

Jastorff, A. M.; Haegler, K.; Maccarrone, G.; Holsboer, F.; Weber, F.; Ziemssen, T.; Turck, C. W.: Regulation of proteins mediating neurodegeneration in experimental autoimmune encephalomyelitis and multiple sclerosis. Proteomics Clinical Applications 3 (11), S. 1273 - 1287 (2009)

Saemann, P.; Knop, M.; Lutz, S.; Czisch, M.; Weber, F.: Nachweis der Anreicherung von "Ultra Small Particles of Iron Oxide" in MS-Läsionen. Nervenarzt 80 (Suppl. 1), S. 12 - 13 (2009)

Knop, M.; Vargas-Leal, V.; Faber, H.; Lutz, S.; Müller-Sarnowski, F.; Hornung, J.; Turck, C. W.; Weber, F.: Prohibitin: prohibiting inflammation in glatiramer acetate-treated multiple sclerosis patients? Multiple Sclerosis 14 (Suppl. 1), S. S132 - S132 (2008)